OSCR

Leprosy neuropathy and demyelinating impairment: How should we interpret this neurophysiological pattern?

Overview

Authors: Diogo Fernandes dos Santos1,2, Iago Resende Carvalho1, Isabella Sabião Borges1, Pedro Henrique Sirotheau Corrêa Alves12, Fernanda de Oliveira Cirino1,2, Douglas Eulálio Antunes1, Raquel Campos Pereira1, Marcus Vinicius Magno Gonçalves3, Isabela Maria Bernardes Goulart1,2
  1. National Reference Center for Sanitary Dermatology and Leprosy, Clinics’ Hospital, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, Minas Gerai, Brazil
  2. Postgraduate Program in Health Sciences, School of Medicine, Federal University of Uberlândia (UFU), Uberlândia, Minas Gerai, Brazil
  3. Professor of Neurology, School of Medicine, University of the Joinville (UNIVILLE), Joinville, South Carolina, Brazil
Journal: PloS one, volume 21, issue 4, article e0343962
Dates: received 7 April 2025; accepted 11 February 2026; published online 8 April 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1371/journal.pone.0343962 · PMID 41950267 · PMCID PMC13061207 · OpenAlex W7152084320
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: human (organism), other condition (population), multiple sclerosis (population), clinical / translational (subfield)
Methods: Statistics, Machine learning
MeSH: Demyelinating Diseases*, Leprosy*, Peripheral Nervous System Diseases*, Adolescent, Adult, Aged, Brazil, Female, Humans, Male, Middle Aged, Mycobacterium leprae, Nerve Conduction Studies, Neural Conduction, Retrospective Studies, Young Adult (* major topic)
Topic: Leprosy Research and Treatment (Infectious Diseases, Medicine), according to OpenAlex
Citations: cited by 1 paper (Europe PMC); 36 references in the paper

Abstract

Introduction/Aims: Leprosy neuropathy (LN) may cause demyelination that worsens during the leprosy reactions (LR). Type-1 LR (T1LR) occurs in patients with cell-mediated immune response against M. leprae, and Type-2 LR (T2LR) occurs in multibacillary cases. The patterns of nerve impairment need to be clarified, as both demyelination and axonal degeneration are commonly observed. This study aimed to describe how to interpret the demyelinating impairment in LN.

Methods: Retrospective observational analysis of leprosy patients in a National Reference Center in Brazil between 2014–2023.

Results: 494 participants were included in this study. 3952 nerves were evaluated, with an average of 5.1 (±5.4) nerves affected per patient. 23.5% (116/494) of patients showed a demyelinating pattern defined by standard criteria, and 20.7% (24/116) presented exclusively demyelinating abnormalities without evidence of secondary axonal loss. 81% (94/116) presented conduction block, and 95.7% (111/116) temporal dispersion, with both conditions concomitant in 76.7% (89/116) of patients. 83.6% (97/116) demonstrated prolonged distal motor latency, and 99.1% (115/116) reduction in conduction velocity. 46.1% had T1LR and 17.9% T2LR. The comparison between patients with and without LR showed higher bacillary load, conduction block, and temporal dispersion in LR patients. 93.1% (108/116) of patients fulfilled neurophysiological criteria for chronic inflammatory demyelinating polyneuropathy (CIDP). Among them, 46.3% presented clinical criteria for atypical CIDP.

Discussion: Leprosy is a spectral disease in which neural damage can manifest in different phenotypes. Demyelinating impairment is frequent and varies according to the clinical form and presence of LR. Although demyelinating impairment is common in the studied population, it does not reflect active disease. LN can also be misdiagnosed as other peripheral neuropathies, especially CIDP, in non-endemic areas.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability

The full anonymized database can be found at https://doi.org/10.5281/zenodo.17297693.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 16 MeSH terms, 34 references.

Cite

This paper

dos Santos, D. F., Carvalho, I. R., Borges, I. S., Alves1, P. H. S. C., de Oliveira Cirino, F., Antunes, D. E., Pereira, R. C., Gonçalves, M. V. M., & Bernardes Goulart, I. M. (2026). Leprosy neuropathy and demyelinating impairment: How should we interpret this neurophysiological pattern? PloS one, 21(4), e0343962. https://doi.org/10.1371/journal.pone.0343962

BibTeX

@article{dossantos2026leprosy,
author = {dos Santos, Diogo Fernandes and Carvalho, Iago Resende and Borges, Isabella Sabião and Alves1, Pedro Henrique Sirotheau Corrêa and de Oliveira Cirino, Fernanda and Antunes, Douglas Eulálio and Pereira, Raquel Campos and Gonçalves, Marcus Vinicius Magno and Bernardes Goulart, Isabela Maria},
title = {{Leprosy neuropathy and demyelinating impairment: How should we interpret this neurophysiological pattern?}},
journal = {PloS one},
year = {2026},
month = apr,
volume = {21},
number = {4},
pages = {e0343962},
publisher = {PLOS},
issn = {1932-6203},
doi = {10.1371/journal.pone.0343962},
url = {https://doi.org/10.1371/journal.pone.0343962},
pmid = {41950267},
pmcid = {PMC13061207}
}

RIS

TY - JOUR
AU - dos Santos, Diogo Fernandes
AU - Carvalho, Iago Resende
AU - Borges, Isabella Sabião
AU - Alves1, Pedro Henrique Sirotheau Corrêa
AU - de Oliveira Cirino, Fernanda
AU - Antunes, Douglas Eulálio
AU - Pereira, Raquel Campos
AU - Gonçalves, Marcus Vinicius Magno
AU - Bernardes Goulart, Isabela Maria
TI - Leprosy neuropathy and demyelinating impairment: How should we interpret this neurophysiological pattern?
T2 - PloS one
J2 - PLoS One
PY - 2026
DA - 2026/04/08
VL - 21
IS - 4
SP - e0343962
SN - 1932-6203
PB - PLOS
DO - 10.1371/journal.pone.0343962
UR - https://doi.org/10.1371/journal.pone.0343962
LA - en
ER -

CSL-JSON

{
"id": "10.1371/journal.pone.0343962",
"type": "article-journal",
"title": "Leprosy neuropathy and demyelinating impairment: How should we interpret this neurophysiological pattern?",
"container-title": "PloS one",
"author": [
{
"family": "dos Santos",
"given": "Diogo Fernandes"
},
{
"family": "Carvalho",
"given": "Iago Resende"
},
{
"family": "Borges",
"given": "Isabella Sabião"
},
{
"family": "Alves1",
"given": "Pedro Henrique Sirotheau Corrêa"
},
{
"family": "de Oliveira Cirino",
"given": "Fernanda"
},
{
"family": "Antunes",
"given": "Douglas Eulálio"
},
{
"family": "Pereira",
"given": "Raquel Campos"
},
{
"family": "Gonçalves",
"given": "Marcus Vinicius Magno"
},
{
"family": "Bernardes Goulart",
"given": "Isabela Maria"
}
],
"container-title-short": "PLoS One",
"volume": "21",
"issue": "4",
"page": "e0343962",
"DOI": "10.1371/journal.pone.0343962",
"PMID": "41950267",
"PMCID": "PMC13061207",
"ISSN": "1932-6203",
"publisher": "PLOS",
"URL": "https://doi.org/10.1371/journal.pone.0343962",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
8
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1371/journal.pntd.0014234
Diagnostic performance of peripheral nerve palpation compared with ultrasonography in leprosy neuropathy: A prospective real-world clinical evaluation.
Journal: PLoS neglected tropical diseases
In common: clinical / translational, other condition, 2 references
[2] doi:10.1371/journal.pntd.0014212
Diagnosis and therapeutic outcomes of biopsy-confirmed Pure Neuritic Leprosy: A two-decade experience.
Journal: PLoS neglected tropical diseases
In common: clinical / translational, 2 references
[3] doi:10.1186/s12883-026-04898-2 [code]
Subclinical peripheral nerve demyelination without overt symptoms in a family with neuronal intranuclear inclusion disease harboring biallelic repeat expansions.
Journal: BMC neurology
In common: multiple sclerosis, clinical / translational, other condition
[4] doi:10.1038/s42255-026-01527-7
The exercise hormone irisin has neuroprotective effects in a mouse model of multiple sclerosis.
Journal: Nature metabolism
In common: multiple sclerosis, clinical / translational, other condition
[5] doi:10.1016/j.nicl.2026.104057 [code]
Tensor-derived diffusion MRI metrics and NODDI in multiple sclerosis classification.
Journal: NeuroImage. Clinical
In common: multiple sclerosis, clinical / translational
[6] doi:10.3389/fimmu.2026.1805464
Chronic low-grade inflammation, genetic susceptibility, and the risk of multiple sclerosis: a prospective cohort study.
Journal: Frontiers in immunology
In common: multiple sclerosis, clinical / translational
[7] doi:10.1016/j.ebiom.2026.106438
Brain network biomarkers for diagnosis and clinical stratification in multiple sclerosis: a longitudinal study integrating individualised structural covariance MRI with high-density EEG.
Journal: EBioMedicine
In common: multiple sclerosis, clinical / translational
[8] doi:10.1128/msystems.00416-26 [code]
Integrative multicohort analysis reveals consistent sex differences in gut microbiota of multiple sclerosis patients.
Journal: mSystems
In common: multiple sclerosis, clinical / translational
[9] doi:10.64898/2026.07.15.26357954 [code]
Portable Ultra-Low Field MRI Deep-Learning Algorithms for White Matter Lesion Segmentation Improve Accuracy and Reflect Clinical Disability in Multiple Sclerosis
Journal: medRxiv (preprint)
In common: multiple sclerosis, clinical / translational
[10] doi:10.1186/s12883-026-05085-z
The use of routinely collected structural neuroimaging to identify cognitive impairment in multiple sclerosis.
Journal: BMC neurology
In common: multiple sclerosis, clinical / translational

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.